Benefits Persist With Inavolisib in Breast Cancer
New findings from the phase 3 INAVO12src trial underscore the durable benefits of inavolisib added to standard therapy for PIK3CA-mutated...
New findings from the phase 3 INAVO12src trial underscore the durable benefits of inavolisib added to standard therapy for PIK3CA-mutated...